REG - CT Global Mgd - CMPI - Compliance with Market Abuse Regulation

CT Global Managed Portfolio TrustAnnouncement

01/12/2025 13:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251201:nRSA7237Ja&default-theme=true

RNS Number : 7237J  CT Global Managed Portfolio - CMPI  01 December 2025

To:       RNS

From:   CT Global Managed Portfolio Trust PLC

Date:    1 December 2025

LEI:      213800ZA6TW45NM9YY31

 

Compliance with Market Abuse Regulation - Statement re. Inside Information

 

CT Global Managed Portfolio Trust PLC (the "Company")

 

The Company announces that it is satisfied that all inside information which
the Directors and the Company may have in the period leading up to the
announcement of its results for the six months ended 30 November 2025 has
previously been, and will continue to be, notified via a regulatory
information service and, therefore, dealings by the Company in its own
securities are permitted.

 

The mandatory closed period under the Market Abuse Regulation will commence on
15 December 2025 and will last until the results for the six months ended 30
November 2025 are published.

 

Name of contact and telephone number for enquiries:

 

Ian Ridge

For Columbia Threadneedle Investment Business Limited

Company Secretary

Telephone: 0131 573 8300

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCEADAFEFFSFFA



            Copyright 2019 Regulatory News Service, all rights reserved